Ogilvy Medical Responds to Subsidiary Employee Glue Poisoning: It Should Be Treated

This article is transferred from: China News Network

Chinanews.com, August 5th, Ogilvy Medical issued an announcement on the 5th that recently, Ogilvy (Ogilvy & Mather), a subsidiary of Ogilvy Medical Products Co., Ltd. Some employees of Jingmen) Medical Supplies Co., Ltd. had symptoms of physical discomfort and were diagnosed as poisoning. As of the date of this announcement, after multiple rounds of health tests on personnel with a history of contact with the workshop, a total of 43 persons with abnormal indicators were treated in the hospital, and one employee suffered from acute myocardial infarction during the treatment. The rest of the staff are still under treatment. Ogilvy Medical said that after the incident, the company attached great importance to it and immediately launched an emergency plan to treat the wounded at all costs. (Zhongxin Finance)

announcement screenshot